Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Proc Natl Acad Sci U S A ; 108(30): 12437-42, 2011 Jul 26.
Article in English | MEDLINE | ID: mdl-21746930

ABSTRACT

Mutations in the gene encoding the transcription factor autoimmune regulator (AIRE) are responsible for autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome. AIRE directs expression of tissue-restricted antigens in the thymic medulla and in lymph node stromal cells and thereby substantially contributes to induction of immunological tolerance to self-antigens. Data from experimental mouse models showed that AIRE deficiency leads to impaired deletion of autospecific T-cell precursors. However, a potential role for AIRE in the function of regulatory T-cell populations, which are known to play a central role in prevention of immunopathology, has remained elusive. Regulatory T cells of CD8(+)CD28(low) phenotype efficiently control immune responses in experimental autoimmune and colitis models in mice. Here we show that CD8(+)CD28(low) regulatory T lymphocytes from AIRE-deficient mice are transcriptionally and phenotypically normal and exert efficient suppression of in vitro immune responses, but completely fail to prevent experimental colitis in vivo. Our data therefore demonstrate that AIRE plays an important role in the in vivo function of a naturally occurring regulatory T-cell population.


Subject(s)
Colitis/immunology , T-Lymphocytes, Regulatory/immunology , Transcription Factors/deficiency , Animals , CD28 Antigens/metabolism , CD8 Antigens/metabolism , Colitis/genetics , Colitis/pathology , Colitis/prevention & control , Disease Models, Animal , Gene Expression Profiling , In Vitro Techniques , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Mutation , Phenotype , Polyendocrinopathies, Autoimmune/genetics , Polyendocrinopathies, Autoimmune/immunology , Receptors, Antigen, T-Cell/metabolism , Self Tolerance , T-Lymphocyte Subsets/immunology , Transcription Factors/genetics , Transcription Factors/immunology , AIRE Protein
2.
Eur J Immunol ; 42(10): 2555-63, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22806332

ABSTRACT

EAE, an animal model for multiple sclerosis, is a Th17- and Th1-cell-mediated auto-immune disease, but the mechanisms leading to priming of encephalitogenic T cells in autoimmune neuroinflammation are poorly understood. To investigate the role of dendritic cells (DCs) in the initiation of autoimmune Th17- and Th1-cell responses and EAE, we used mice transgenic for a simian diphtheria toxin receptor (DTR) expressed under the control of the murine CD11c promoter (CD11c-DTR mice o nC57BL/6 background).EAE was induced by immunization with myelin oligodendrocyte glycoprotein (MOG) protein in CFA. DCs were depleted on the day before and 8 days after MOG immunization. The mean clinical EAE score was only mildly reduced in DC-depleted mice when DCs were ablated before EAE induction. The frequency of activated Th cells was not altered, and MOG-induced Th17 or Th1-cell responses were not altered, in the spleens of DC-depleted mice. Similar results were obtained if DCs were ablated the first 10 days after MOG immunization with repeated DC depletions. Unexpectedly, transient depletion of DCs did not affect priming or differentiation of MOG-induced Th17 and Th1-cell responses or the incidence of EAE. Thus, the mechanism of priming of Th cells in EAE remains to be elucidated.


Subject(s)
Dendritic Cells/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Multiple Sclerosis/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Animals , CD11c Antigen/genetics , Cells, Cultured , Diphtheria Toxin/administration & dosage , Female , Heparin-binding EGF-like Growth Factor , Humans , Intercellular Signaling Peptides and Proteins/genetics , Lymphocyte Activation/drug effects , Lymphocyte Activation/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myelin-Oligodendrocyte Glycoprotein/immunology , Promoter Regions, Genetic
3.
Eur J Immunol ; 41(1): 235-45, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21182094

ABSTRACT

Autoimmune polyendocrine syndrome type 1 (APS-1) is a multiorgan autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene. Chronic mucocutaneous candidiasis, hypoparathyroidism and adrenal failure are hallmarks of the disease. The critical mechanisms causing chronic mucocutaneous candidiasis in APS-1 patients have not been identified although autoantibodies to cytokines are implicated in the pathogenesis. To investigate whether the Th reactivity to Candida albicans (C. albicans) and other stimuli was altered, we isolated PBMC from APS-1 patients and matched healthy controls. The Th17 pathway was upregulated in response to C. albicans in APS-1 patients, whereas the IL-22 secretion was reduced. Autoantibodies against IL-22, IL-17A and IL-17F were detected in sera from APS-1 patients by immunoprecipitation. In addition, Aire-deficient (Aire(0/0) ) mice were much more susceptible than Aire(+/+) mice to mucosal candidiasis and C. albicans-induced Th17- and Th1-cell responses were increased in Aire(0/0) mice. Thus an excessive IL-17A reactivity towards C. albicans was observed in APS-1 patients and Aire(0/0) mice.


Subject(s)
Candida albicans/immunology , Candidiasis/immunology , Interleukin-17/immunology , Adolescent , Adult , Animals , Autoantibodies/blood , Autoantibodies/immunology , Disease Models, Animal , Female , Humans , Interleukins/immunology , Interleukins/metabolism , Leukocytes, Mononuclear/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Mutant Strains , Middle Aged , Polyendocrinopathies, Autoimmune/immunology , Th17 Cells/immunology , Transcription Factors/genetics , Up-Regulation/immunology , Young Adult , AIRE Protein , Interleukin-22
4.
Eur J Gastroenterol Hepatol ; 22(4): 429-36, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19829122

ABSTRACT

OBJECTIVE: Autoantibodies against goblet cells in the gastrointestinal mucosa have been described in patients with inflammatory bowel disease (IBD) but a corresponding autoantigen has not yet been identified. The aim of this study was to identify such an antigen. METHODS: First, 10 candidate autoantigens were discarded based on double stainings of appendiceal sections and a mucin-producing cell line (HT29-mtx). Second, an appendiceal cDNA library was immunoscreened with IBD sera. RESULTS: Three out of 48 positive clones were identified as complement C3. Using immunoprecipitation of in vitro transcribed and translated C3, seven of 17 primary sclerosing cholangitis patient sera, 15 of 65 IBD sera, and none out of 54 sera from healthy blood donors showed C3 immunoreactivity. The results were confirmed using western blot and an enzyme-linked immunosorbent assay with alternative sources of C3 protein. CONCLUSION: In conclusion, we have identified complement C3 as a potential autoantigen in IBD and primary sclerosing cholangitis.


Subject(s)
Appendix/immunology , Autoantigens/immunology , Complement C3/immunology , Goblet Cells/immunology , Inflammatory Bowel Diseases/immunology , Antibody Specificity/immunology , Appendix/pathology , Autoantigens/analysis , Biomarkers/analysis , Cholangitis, Sclerosing/immunology , Cholangitis, Sclerosing/pathology , Complement C3/analysis , HT29 Cells , Humans , Inflammatory Bowel Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL